Sarepta Therapeutics (SRPT) PT Raised to $35 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $18.56 --0%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 44
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 44
Join SI Premium – FREE
Baird analyst Brian Skorney raised the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $35.00 (from $30.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Meta Platforms Inc. (META) PT Raised to $800 at DA Davidson on Q3 Beat
- Sarepta Therapeutics to Announce Third Quarter 2026 Financial Results
- Shake Shack (SHAK) PT Raised to $73 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
